EMD-37516

Single-particle
2.92 Å
EMD-37516 Deposition: 22/09/2023
Map released: 28/02/2024
Last modified: 23/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-37516

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8wgv summary report (pdf.gz) Map-8wgv FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

BA.2(S375) Spike (S6P)/hACE2 complex

EMD-37516

Single-particle
2.92 Å
EMD-37516 Deposition: 22/09/2023
Map released: 28/02/2024
Last modified: 23/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: BA.2(S375) Spike (S6P)/hACE2 complex
Fitted models: 8wgv

Deposition Authors: Wei X , Zhang Z
The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis.
PUBMED: 38454157
DOI: doi:10.1038/s41590-024-01776-2
ISSN: 1529-2916